Pictet & Cie (Europe) Sa Regeneron Pharmaceuticals, Inc. Transaction History

Pictet & Cie (Europe) Sa

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 01, 2019	SELL	$372.08 - $439.57 $314,407 - $371,436	-845 Closed	0 $0
Q4 2018 Jan 31, 2019	SELL	$335.82 - $403.04 $67,164 - $80,608	-200 Reduced 19.14%	845 $316,000
Q3 2018 Nov 07, 2018	SELL	$351.14 - $408.51 $28,091 - $32,680	-80 Reduced 7.11%	1,045 $422,000
Q2 2018 Aug 10, 2018	SELL	$284.6 - $344.99 $102,740 - $124,541	-361 Reduced 24.29%	1,125 $388,000
Q1 2018 May 09, 2018	BUY	$315.82 - $393.78 $59,374 - $74,030	188 Added 14.48%	1,486 $512,000
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $103,285 - $135,345	288 Added 28.51%	1,298 $488,000
Q3 2017 Nov 07, 2017	BUY	$431.38 - $504.0 $435,693 - $509,040	1,010	1,010 $452,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.